275 related articles for article (PubMed ID: 8218358)
1. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
Moghimi SM; Muir IS; Illum L; Davis SS; Kolb-Bachofen V
Biochim Biophys Acta; 1993 Nov; 1179(2):157-65. PubMed ID: 8218358
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
Moghimi SM; Hedeman H; Muir IS; Illum L; Davis SS
Biochim Biophys Acta; 1993 Jul; 1157(3):233-40. PubMed ID: 8323953
[TBL] [Abstract][Full Text] [Related]
3. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.
Moghimi SM; Gray T
Clin Sci (Lond); 1997 Oct; 93(4):371-9. PubMed ID: 9404230
[TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
Moghimi SM; Hedeman H; Christy NM; Illum L; Davis SS
J Leukoc Biol; 1993 Dec; 54(6):513-7. PubMed ID: 8245702
[TBL] [Abstract][Full Text] [Related]
5. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.
Moghimi SM; Hawley AE; Christy NM; Gray T; Illum L; Davis SS
FEBS Lett; 1994 May; 344(1):25-30. PubMed ID: 8181558
[TBL] [Abstract][Full Text] [Related]
6. Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?
Moghimi SM
Biochim Biophys Acta; 1997 Jul; 1336(1):1-6. PubMed ID: 9271243
[TBL] [Abstract][Full Text] [Related]
7. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres.
Norman ME; Williams P; Illum L
Biomaterials; 1992; 13(12):841-9. PubMed ID: 1457677
[TBL] [Abstract][Full Text] [Related]
8. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.
Moghimi SM; Pavey KD; Hunter AC
FEBS Lett; 2003 Jul; 547(1-3):177-82. PubMed ID: 12860409
[TBL] [Abstract][Full Text] [Related]
9. Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
Moghimi SM; Hedeman H; Illum L; Davis SS
Clin Sci (Lond); 1993 Jun; 84(6):605-9. PubMed ID: 8334806
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
Armstrong TI; Moghimi SM; Davis SS; Illum L
Pharm Res; 1997 Nov; 14(11):1629-33. PubMed ID: 9434285
[TBL] [Abstract][Full Text] [Related]
11. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM
J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527
[TBL] [Abstract][Full Text] [Related]
12. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging.
Moghimi SM
Biochim Biophys Acta; 1999 Oct; 1472(1-2):399-403. PubMed ID: 10572962
[TBL] [Abstract][Full Text] [Related]
13. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Neal JC; Stolnik S; Garnett MC; Davis SS; Illum L
Pharm Res; 1998 Feb; 15(2):318-24. PubMed ID: 9523321
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing.
Pedraza CE; Nikolcheva LG; Kaartinen MT; Barralet JE; McKee MD
Bone; 2008 Oct; 43(4):708-16. PubMed ID: 18656563
[TBL] [Abstract][Full Text] [Related]
15. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
Khattab MA; Farr SJ; Taylor G; Kellaway IW
J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
[TBL] [Abstract][Full Text] [Related]
16. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.
Neal JC; Stolnik S; Schacht E; Kenawy ER; Garnett MC; Davis SS; Illum L
J Pharm Sci; 1998 Oct; 87(10):1242-8. PubMed ID: 9758684
[TBL] [Abstract][Full Text] [Related]
17. Influence of the surfactant concentration on the body distribution of nanoparticles.
Araujo L; Löbenberg R; Kreuter J
J Drug Target; 1999; 6(5):373-85. PubMed ID: 10342385
[TBL] [Abstract][Full Text] [Related]
18. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers.
Moghimi SM
Biochim Biophys Acta; 2002 Jun; 1590(1-3):131-9. PubMed ID: 12063176
[TBL] [Abstract][Full Text] [Related]
19. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.
Carrstensen H; Müller RH; Müller BW
Clin Nutr; 1992 Oct; 11(5):289-97. PubMed ID: 16840011
[TBL] [Abstract][Full Text] [Related]
20. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
Illum L; Davis SS; Müller RH; Mak E; West P
Life Sci; 1987 Jan; 40(4):367-74. PubMed ID: 3807638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
